We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Search
Filters
9068 Results

Congress Abstract

Exploring hypoxia in prostate cancer with T2-weighted MRI radiomics and pimonidazole scoring.

Authors:

Michelle Leech1, Ralph Leijenaar2, Tord Hompland3, John Gaffney4, Heidi Lyng5, Laure Marignol1

1Trinity St. James's Cancer Institute, Applied Radiation Therapy Trinity, Trinity College, Radiation Therapy, Dublin, Ireland; 2Oncoradiomics SA, Oncoradiomics, Liége, Belgium; 3Radiumhospitalet Oslo University Hospital,, Radiation Biology, Oslo, Norway; 4St. Luke's Radiation Oncology Network, Radiation Oncology, Dublin, Ireland; 5Radiumhospitalet Oslo University Hospita, Radiation Biology, Oslo, Norway

Show Affiliations
2021
Poster
ESTRO 2021

Journal Article

Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial
Authors: Alexander V. Louie, Erik van Werkhoven, Hanbo Chen, Egbert F. Smit, Marinus A. Paul, Joachim Widder, Harry J.M. Groen, Ben E.E.M. van den Borne, Katrien De Jaeger, Ben J. Slotman, Suresh Senan
2015
Radiotherapy and Oncology

Journal Article

Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer
Authors: Jennifer C. Ho, Penny Fang, Carlos E. Cardenas, Abdallah S.R. Mohamed, Clifton D. Fuller, Pamela K. Allen, Priya R. Bhosale, Michael M. Frumovitz, Anuja Jhingran, Ann H. Klopp
2019
Radiotherapy and Oncology

Webcast

Radiomics – Clinical challenges and opportunities – Will radiomics change our practice in the next years?
Authors: Martina Sollini
2018
ESTRO 37

Webcast

Overview of the molecular interactions between radiotherapy and the immune system and immune checkpoint inhibitors
Authors: Alan Melcher
2018
ESTRO 37

Webcast

Understanding and targeting the underlying drivers of tumor hypoxia
Authors: Bradly Wouters
2018
ESTRO 37

Journal Article

The relative biological effectiveness of antiprotons
Authors: Michael H. Holzscheiter, Jan Alsner, Niels Bassler, Rebecca Boll, Massimo Caccia, Helge Knudsen, Carl Maggiore, Jørgen B. Petersen, Stefan Sellner, Tina Straße, Brita Singers Sørensen, Jens Overgaard
2016
Radiotherapy and Oncology

Congress Abstract

HDR brachytherapy for treatment of primary cutaneous lymphoma at complex sites and curved surfaces
Authors:

Van Sim1, Irene De Francesco1, Sean Whittaker2, Fiona Child2, Mary Wain2, Sarah Aldridge3, Emma Jones3, Kirsty Freeman3, Stephen Morris1

1Guy's Cancer Centre, Clinical Oncology, London, United Kingdom; 2Guy's and St Thomas' NHS Foundation Trust, St John's Institute of Dermatology, London, United Kingdom; 3Guy's Cancer Centre, Radiotherapy, London, United Kingdom

Show Affiliations
2021
Poster
ESTRO 2021

Congress Abstract

Model based proton therapy patient selection in the context of limited slot availability
Authors:

Jan Unkelbach1, David Papp2

1University Hospital Zurich, Radiation Oncology, Zurich, Switzerland; 2North Carolina State University, Mathematics, Raleigh, USA

Show Affiliations
2021
Poster
ESTRO 2021

Journal Article

Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy
Authors: Olga Hamming-Vrieze, Simon R. van Kranen, Wilma D. Heemsbergen, Charlotte A.H. Lange, Michiel W.M. van den Brekel, Marcel Verheij, Coen R.N. Rasch, Jan Jakob Sonke
2017
Radiotherapy and Oncology
*:*